Genomics & Gene Editing
Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.
199 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 26 |
Invesco
Atlanta,
Georgia
| $1.88B | -$29.1M | 27 | 0.7% | Reduced |
|
| 27 |
UBS Group
Zurich,
Switzerland
| $1.81B | +$62.3M | 79 | 0.78% | Increased |
|
| 28 |
Dimensional Fund Advisors
Austin,
Texas
| $1.79B | -$60.5M | 34 | 0.74% | Reduced |
|
| 29 |
Loomis, Sayles & Company
Boston,
Massachusetts
| $1.72B | +$328M | 6 | 3.66% | Increased |
|
| 30 |
Pictet Asset Management (UK)
London,
United Kingdom
| $1.67B | +$151M | 13 | 4.13% | Increased |
|
| 31 |
Ameriprise
Minneapolis,
Minnesota
| $1.51B | +$43.7M | 33 | 0.68% | Increased |
|
| 32 |
ClearBridge Investments
New York
| $1.5B | +$57.2M | 15 | 1.41% | Increased |
|
| 33 |
Parnassus Investments
San Francisco,
California
| $1.44B | -$289M | 2 | 5.8% | Reduced |
|
| 34 |
TIAA CREF Investment Management
New York
| $1.34B | +$24.8M | 43 | 0.9% | Increased |
|
| 35 |
Jennison Associates
New York
| $1.28B | -$24.3M | 16 | 1.27% | Reduced |
|
| 36 |
American Century Companies
Kansas City,
Missouri
| $1.27B | -$36.3M | 16 | 1.29% | Reduced |
|
| 37 |
Charles Schwab
San Francisco,
California
| $1.27B | +$63.2M | 43 | 0.98% | Increased |
|
| 38 |
Legal & General Group
London,
United Kingdom
| $1.23B | -$3.08M | 43 | 0.94% | Reduced |
|
| 39 |
UBS AM
Chicago,
Illinois
| $1.23B | -$15.4M | 27 | 0.97% | Reduced |
|
| 40 |
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1.22B | +$705K | 64 | 0.55% | Increased |
|
| 41 |
Edgewood Management
Greenwich,
Connecticut
| $1.22B | -$5.15M | 1 | 4.86% | Reduced |
|
| 42 |
Brown Advisory
Baltimore,
Maryland
| $1.21B | -$23.1M | 13 | 3.91% | Reduced |
|
| 43 |
Millennium Management
New York
| $1.11B | +$343M | 56 | 1.48% | Increased |
|
| 44 |
OrbiMed
New York
| $1.1B | +$157M | 18 | 13.6% | Increased |
|
| 45 |
Renaissance Technologies
New York
| $1.09B | +$150M | 47 | 1.2% | Increased |
|
| 46 |
D.E. Shaw & Co
New York
| $1.05B | -$75.6M | 40 | 1.43% | Reduced |
|
| 47 |
Credit Suisse
Zurich,
Switzerland
| $1.03B | +$156M | 43 | 0.96% | Increased |
|
| 48 |
Select Equity Group
New York
| $1.01B | +$81.8M | 4 | 8.31% | Increased |
|
| 49 |
Swiss National Bank
Zurich,
Switzerland
| $936M | -$103M | 32 | 1.14% | Reduced |
|
| 50 |
Allianz Asset Management
Munich,
Germany
| $931M | +$20.4M | 24 | 0.89% | Increased |
|